• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » CenterWatch Monthly August 2008 Issue

CenterWatch Monthly August 2008 Issue

September 3, 2008
CenterWatch Staff

Central and Eastern Europe Triples Global Trial Participation

The number of global clinical trials initiated in Central and Eastern Europe more than tripled from 2002 through 2007. While the entire CEE region has less than half the population of either India or China, it had more than twice the number of global trials initiated last year as all of the Asia-Pacific region. With the growth of the CEE region has come increased advantages and challenges. Costs have increased, but access to large treatment-naïve populations due to centralized healthcare systems offsets them. Though the EU Clinical Trial Directive was implemented in 2004, there is no uniform regulatory process that governs the entire region, and each country also has its own local culture, so local site management is important.

As Trial Results Reporting Deadline Looms, Confusion Grows
On Sept. 27, 2008--one year after implementation of FDAAA--the so-called “basic results” reporting provisions become effective.The law requires that basic results from clinical trials of all FDA-approved drugs or devices be submitted to ClinicalTrials.gov no later than one year after the primary completion date of the trial. The deadline has pharmaceutical companies scrambling not only to comply with the requirement, but also to get clarity from federal regulators.

GCP Regulation in Europe in 2008
In an era in which business regularly complains about EU regulation, the clinical research community’s attitude to Good Clinical Practice (GCP) makes a refreshing change. Both the regulations and the inspectors who enforce them in this area have gained and retained the respect of the industry they regulate, including the 2005 EU Directive on GCP.

Eye On: HIV/AIDS
Infection with the Human Immunodeficiency Virus (HIV), if left untreated, is followed by development of the Acquired Immune Deficiency Syndrome (AIDS). HIV-1 infection leads to progressive destruction of certain immune system cells, known as CD4+ cells, resulting in the state of immune system dysfunction known as AIDS.

To read the full articles for this issue or for more information on these and other breaking stories, please click here.

Upcoming Events

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Revamp-360x240.png

    Califf Calls for Major Evidence Generation Revamp, Experts’ Opinions Differ

  • AskTheExpertsGreen-360x240.png

    Ask the Experts: Managing Investigational Products

  • SurveywBlueBackground-360x240.png

    Survey Outlines Site Challenges, Successes on Diversity

  • PatientCentricity-360x240.png

    Site Spotlight: DM Clinical Shows Patient Centricity Doesn’t Have to Break the Bank

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing